Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: J Biophotonics. 2019 Dec 8;13(3):e201960014. doi: 10.1002/jbio.201960014

Table 1.

Demographics of enrolled subjects who received at least one treatment.

STARS 1 STARS 2
Characteristic Total (n = 60) HF-LED-RL (n = 36) Mock (n = 24) P-value Total (n = 54) HF-LED-RL (n = 33) Mock (n = 21) P-value
Age, years 55.1 ± 13.0 54.7 ± 11.5 55.6 ± 15.2 0.63 56.2 ± 15.5 55.0 ± 16.0 58.0 ± 14.7 0.53
Sex
 Male 44 (73.3%) 26 (72.2%) 18 (75.0%) 1.00 40 (74.0%) 23 (69.7%) 17 (81.0%) 0.53
 Female 16 (26.7%) 10 (27.8%) 6 (25.0%) 14 (26.0%) 10 (30.3%) 4 (19.0%)
Race and ethnicity
 Caucasian, Not Hispanic or Latino 36 (60.0%) 19 (52.8%) 17 (70.8%) 0.75 54 (100%) 33 (100%) 21 (100%) N/A
 Caucasian, Hispanic or Latino 4 (6.7%) 3 (8.3%) 1 (4.2%) -- -- --
 Black or African American 16 (26.7%) 11 (30.6%) 5 (20.8%) -- -- --
 Asian 3 (5.0%) 2 (5.6%) 1 (4.2%) -- -- --
 Native Hawaiian or Other Pacific Islander 1 (1.7%) 1 (2.8%) 0 (0.0%) -- -- --

Age is presented as mean ± SD. Categorical variables are presented as n (%). P-values were calculated by two-sided Wilcoxon ranked sum test for age and Fisher’s exact test for categorical variables. P-values ≤ 0.05 were considered statistically significant.

HF-LED-RL: high fluence light-emitting diode-red light

A total of 55 subjects were enrolled in STARS 2, but 1 subject did not receive the assigned treatment since the intervention was halted per the study protocol.